Ryan Specialty (NYSE: RYAN) awards 33,715 stock options to EVP & counsel

Rhea-AI Filing Summary

KATZ MARK STEPHEN reported acquisition or exercise transactions in this Form 4 filing.

Ryan Specialty Holdings reported that EVP & General Counsel Mark Stephen Katz received a grant of 33,715 Executive Chairman stock options on May 5, 2026. The options have a strike price of $29.66, vest in three equal parts on July 1 of 2029, 2030 and 2031, and expire on May 5, 2036. Following this award, he holds 33,715 options, each exercisable into one share of Class A common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KATZ MARK STEPHEN

Role EVP & General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Executive Chairman Stock Option	33,715	$0.00	--

Holdings After Transaction: Executive Chairman Stock Option — 33,715 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 33,715 options Exercise price: $29.66 per share Total options after grant: 33,715 options +2 more

5 metrics

Options granted 33,715 options Executive Chairman stock option grant on May 5, 2026

Exercise price $29.66 per share Strike price for Executive Chairman stock options

Total options after grant 33,715 options Holdings following reported transaction

Option expiration date May 5, 2036 End of exercise period for granted options

Vesting dates July 1, 2029, 2030, 2031 Three equal vesting installments for the grant

Key Terms

Executive Chairman Stock Option, Class A common stock, Rule 16(b)(3)

3 terms

Executive Chairman Stock Option financial

"security_title: "Executive Chairman Stock Option""

Class A common stock financial

"exercisable on a 1-for-1 basis for shares of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 16(b)(3) regulatory

"approved by the compensation and governance committee ... for the purposes of rule 16(b)(3)"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZ MARK STEPHEN

(Last) (First) (Middle)

155 NORTH WACKER DRIVE, SUITE 4000

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RYAN SPECIALTY HOLDINGS, INC. [ RYAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Executive Chairman Stock Option	$29.66	05/05/2026		A		33,715		(1)	05/05/2036	Class A Common Stock	33,715	$0	33,715	D

Explanation of Responses:

1. The stock options vest in equal amounts on July 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).

Remarks:

	/s/ Mark S. Katz	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did RYAN report for Mark Stephen Katz?

RYAN reported that EVP & General Counsel Mark Stephen Katz received a grant of 33,715 Executive Chairman stock options. The award is a compensation-related acquisition, not an open-market purchase or sale, and is disclosed as a routine Form 4 insider transaction.

What is the exercise price of the new RYAN stock options granted to Katz?

The new Executive Chairman stock options granted to Katz carry an exercise price of $29.66 per share. Each option can be exercised on a 1-for-1 basis for Class A common stock, meaning one option converts into one share at that strike price.

How many RYAN options does Mark Stephen Katz hold after this Form 4 grant?

After this grant, Mark Stephen Katz holds a total of 33,715 Executive Chairman stock options. All of these options relate to Class A common stock and were acquired in a single compensation award reported in the Form 4 filing for Ryan Specialty Holdings.

When do the newly granted RYAN options to Katz vest?

The options vest in three equal installments on July 1, 2029, July 1, 2030, and July 1, 2031. This time-based vesting schedule means Katz earns one-third of the award on each of those dates, subject to the terms of the grant.

What is the expiration date of the RYAN Executive Chairman stock options?

The Executive Chairman stock options granted to Katz expire on May 5, 2036. After that expiration date, any unexercised options become invalid, so the 10-year term defines the maximum window during which they can be exercised into Class A common stock.

Were the RYAN stock option grants approved by a board committee?

Yes. The grant was approved by the compensation and governance committee of Ryan Specialty’s board of directors. The footnote explains this approval was for purposes of Rule 16(b)(3), which helps qualify the transaction for certain exemptions under U.S. securities regulations.